Vaccines play a vital role in improving the health of millions worldwide. Secretary-General Ban Ki-moon has made immunization a key part of the UN Global Strategy for Women’s and Children’s Health, aimed at saving the lives of 16 million women and children between 2011 and 2015. But for low-income countries there remains a major challenge – access.
Combination vaccines have become the preferred choice for immunizing children in high- and middle-income countries. However, these new vaccines are prohibitively expensive for poorer countries, causing them to rely on older, less expensive vaccines. This product divergence decreases economies of scale once used for purchasing vaccines, and eliminates the financial incentive for manufacturers to maintain production of less expensive vaccines, or even to develop new vaccines for diseases affecting developing countries.
Rubén Proaño’s research focuses on how to price vaccines optimally to satisfy countries’ vaccine demand, while providing a reasonable profit for producers. In this talk Dr Proaño will suggest how major vaccine purchasers such as UNICEF or PAHO can influence the vaccine market by their purchases so that vaccine manufacturers increase their profits, and developing countries gain access to affordable complex combination vaccines.
Conference Room 7, Temporary North Lawn Building, United Nations Headquarters, New York